We are live on ! Find out more
PLSM

Pulsenmore Ltd

2.41 USD
-0.01
0.41%
At close Updated Sep 15, 4:00 PM EDT
Pre-market
After hours
2.32
-0.09
3.73%
1 day
-0.41%
5 days
-4.37%
1 month
-16.61%
3 months
-37.4%
6 months
-43.95%
Year to date
-67.26%
1 year
-67.26%
5 years
-67.26%
10 years
-67.26%
 

About: Pulsenmore Ltd is an emerging medical device company engaged in the research, development, manufacturing, marketing, and sale of non-invasive portable ultrasound solutions for home use. Its products include the Pulsenmore ES and Pulsenmore FC, along with the early-stage Pulsenmore MC, collectively referred to as Pulsenmore Products, enabling remote ultrasound scans in gynecology and other fields such as pulmonary, cardiology, and urology through telemedicine. The Company operates in a single segment focused on developing and commercializing portable ultrasound technologies, with Israel contributing the majority of its revenue.

Employees: 63

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 0%
Neutral 100%
Negative 0%
Neutral
PRNewsWire
7 days ago
Pulsenmore Expands into Fertility Care: Completes CE European Registration of Home Ultrasound System for Follicular Monitoring
The Pulsenmore FC system is designed to enable women undergoing IVF and fertility preservation treatments to self-perform ultrasound scans from home  This registration marks the Company's second product authorized in Europe and its first expansion beyond prenatal care into the broader women's health market OMER, Israel, Sept. 8, 2026 /PRNewswire/ -- Pulsenmore Ltd.
Pulsenmore Expands into Fertility Care: Completes CE European Registration of Home Ultrasound System for Follicular Monitoring
Neutral
PRNewsWire
15 days ago
Pulsenmore Ltd. Announces Financial Results and Business Highlights for the First Half of 2026
Management to Host Webcast today at 8:30 am ET to discuss Results and Provide Business Update OMER, Israel, Aug. 31, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a leading innovator in remote maternal-fetal healthcare and home ultrasound solutions, presents the key operational, commercial, regulatory, and technological achievements as well as financial updates for the six month period ended June 30, 2026.
Pulsenmore Ltd. Announces Financial Results and Business Highlights for the First Half of 2026
Neutral
PRNewsWire
22 days ago
Pulsenmore Ltd. To Announce Financial Results and Business Highlights and Hold Conference Call for the First Half of 2026
OMER, Israel, Aug. 24, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a leading innovator in remote maternal-fetal healthcare and home ultrasound solutions, today announces that it will release its financial results and business highlights for the six months ended June 30, 2026 on August 31, 2026 at 8:30 am ET.
Pulsenmore Ltd. To Announce Financial Results and Business Highlights and Hold Conference Call for the First Half of 2026
Neutral
PRNewsWire
27 days ago
Pulsenmore Expands Its Home Ultrasound Activity in Israel: Ichilov Adopts the Technology, Expanding Access to At-Home Pregnancy Monitoring
The Company's home ultrasound technology will be integrated at Lis Maternity and Women's Hospital at Ichilov, expanding the ability to incorporate at-home ultrasound scans as part of pregnancy monitoring RAMAT GAN, Israel, Aug. 19, 2026 /PRNewswire/ -- Pulsenmore (NASDAQ: PLSM) (TASE: PLSM), a developer of home ultrasound solutions supported by remote medical guidance, today announced the expansion of its activities in Israel. The Company's home ultrasound technology will be integrated at the Lis Maternity and Women's Hospital at Ichilov, a major center for women's and maternity care in Israel, joining other medical centers that already incorporate the technology into pregnancy monitoring pathways.
Pulsenmore Expands Its Home Ultrasound Activity in Israel: Ichilov Adopts the Technology, Expanding Access to At-Home Pregnancy Monitoring
Neutral
PRNewsWire
29 days ago
Pulsenmore Receives Second AI Grant Within One Month: Israel Innovation Authority Approves $1.27 Million for SmartScan AI Program
The new grant brings the total AI grants approved for Pulsenmore over the past month to approximately $1.6 million, supporting two programs with a combined scope of approximately $3.12 million. The program is designed to advance the next generation of home ultrasound through AI-powered real-time ultrasound analysis and dynamic guidance of the image acquisition process, with the goal of improving scan quality and consistency and enabling home ultrasound to be deployed at greater scale.
Pulsenmore Receives Second AI Grant Within One Month: Israel Innovation Authority Approves $1.27 Million for SmartScan AI Program
Neutral
PRNewsWire
2 months ago
Pulsenmore Selected for Israel Innovation Authority and Ministry of Health Program to Lead an $1 Million AI Development Project
The program is designed to enable Pulsenmore to develop and clinically validate AI applications that improve clinical workflow efficiency and enhance the scalability of the company's home ultrasound platform. RAMAT GAN, Israel, July 13, 2026 /PRNewswire/ -- Pulsenmore Ltd.
Pulsenmore Selected for Israel Innovation Authority and Ministry of Health Program to Lead an $1 Million AI Development Project
Neutral
PRNewsWire
2 months ago
Pulsenmore Announces Pricing of $7.5 Million Private Placement with a Single Healthcare Focused Institutional Investor
RAMAT GAN, Israel, June 25, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced that it has entered into a securities purchase agreement with a healthcare-focused institutional investor, for the purchase and sale of 1,562,500 ordinary shares (or pre-funded warrants in lieu thereof) and ordinary warrants to purchase up to 1,562,500 ordinary shares in a private placement at a combined purchase price of $4.80 per ordinary share and accompanying warrant  (or $4.7999 per pre-funded warrant and accompanying ordinary warrant), representing a premium to the Nasdaq Minimum Price under Nasdaq rules.
Pulsenmore Announces Pricing of $7.5 Million Private Placement with a Single Healthcare Focused Institutional Investor
Neutral
PRNewsWire
2 months ago
Pulsenmore Announces Strategic Partnership with Ouma Health to Expand Access to Remote Prenatal Care Across the United States
FDA-authorized home ultrasound technology to be integrated into Ouma Health's virtual maternity care model, creating a scalable pathway to expand the adoption of home ultrasound in prenatal care across the United States RAMAT GAN, Israel, June 24, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced a strategic partnership with Ouma Health, a leading provider of virtual maternity care solutions in the United States.
Pulsenmore Announces Strategic Partnership with Ouma Health to Expand Access to Remote Prenatal Care Across the United States
Neutral
PRNewsWire
5 months ago
Pulsenmore Announces Full Year 2025 Financial Results and Webcast
Management to Host Conference Call and Webcast today at 8:30am ET to Discuss Results and Provide Business Update OMER, Israel, March 30, 2026  /PRNewswire/ – Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced financial results for the full year ended December 31, 2025.
Pulsenmore Announces Full Year 2025 Financial Results and Webcast
Neutral
PRNewsWire
5 months ago
Pulsenmore Announces Full Year 2025 Earnings Conference Call
OMER, Israel, March 25, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced that it will release its financial results for full year 2025 on March 30, 2026 at 8:30 a.m.
Pulsenmore Announces Full Year 2025 Earnings Conference Call
Price charts implemented using Lightweight Charts™